- Home
- Equipment
- north america
- bladder tumor bt test
Show results for
Refine by
Bladder Tumor Bt Test Equipment Supplied In North America
4 equipment items found
by:Antech Diagnostics based inFountain Valley, CALIFORNIA (USA)
Antech’s molecular diagnostics use and develop novel technologies that enable faster and more personalized diagnoses. With tests such as CADET® BRAF/PLUS and comprehensive PCR panels, we are the innovative leader in molecular research and testing. ...
Manufactured by:Veracyte, Inc. based inSouth San Francisco, CALIFORNIA (USA)
Revealing cancer molecular subtype to inform treatment decisions. Decipher Bladder is a genomic test that measures the molecular profile of bladder cancer using gene expression analysis from transurethral resected bladder tumor specimens. The test was developed for bladder cancer patients with high-grade non-muscle-invasive disease who are being considered for treatment and patients with ...
Manufactured by:Nucleix Ltd. based inSan Diego, CALIFORNIA (USA)
Bladder cancer is the 5th most common cancer in the western world, and 70%-80% of the patients are diagnosed with non-muscle invasive disease. There are estimated 400,000 to 800,000 active bladder cancer patients in the United States, as well as 1 to 2 million in Europe, who undergo local resection of the tumor and then have 1-4 follow-up visits each year due to the high recurrence rate of the ...
Manufactured by:Pacific Edge Ltd based inDunedin,, NEW ZEALAND
Cxbladder is a non-invasive genomic urine test that quickly and accurately detects or rules out bladder cancer. The tests works at a molecular level, measuring five biomarker genes to detect the presence or absence of bladder cancer1, and comes as a suite of three product variations, each optimised for a different point in the patient ...